EichorEICHOR
Study identifier: NCT04702451 Synced from ClinicalTrials.gov · August 04, 2026
● Completed

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Condition: Atrial Fibrillation  ·  Sponsor: Volta Medical

PhaseNA
Planned participants377
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation strategy targeting areas of spatio-temporal dispersion in combination with PVI is superior to an anatomical ablation strategy targeting PVI alone for the treatment of persistent AF.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (26)

Grandview Medical CenterBirmingham, Alabama, United States
Ascension St. Vincent'sJacksonville, Florida, United States
Washington UniversitySt Louis, Missouri, United States
Northwell HealthNew York, New York, United States
New York Presbyterian Queens HospitalQueens, New York, United States
Ohio State UniversityColumbus, Ohio, United States
Rhode Island HospitalProvidence, Rhode Island, United States
Inova FairfaxFalls Church, Virginia, United States
OLV AalstAalst, Belgium
UZ LeuvenLeuven, Belgium
Pôle Santé RépubliqueClermont-Ferrand, France
Hôpital Saint PhilibertLomme, France

+ 14 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →